Search results for "heart disease"

showing 10 items of 489 documents

Selected enzyme activities in mouse cardiac muscle during training and terminated training

1984

We studied the effects of running-training, heavy exercise and termination of training on the heart weight, the ratio heart to body weight and the cardiac muscle activities of actomyosin ATPase, citrate synthase, succinate dehydrogenase, cytochrome c oxidase, malate dehydrogenase, adenylate kinase and beta-glucuronidase with adult male NMRI-mice. Stable hypertrophy (6-7%), estimated by the ratio heart or ventricle weight to body weight, was achieved by 28 exercises and it was dependent on the running speed (20 vs. 25 m X min-1). The withdrawal of training for 5-61 days did not permanently decrease the heart weight or the heart to body weight ratio to the level of sedentary controls. The act…

Malemedicine.medical_specialtyTime FactorsHeart diseasePhysiologyATPasePhysical ExertionCardiomegalyMice Inbred StrainsCitrate (si)-SynthaseBiologyMalate dehydrogenaseMitochondria HeartMuscle hypertrophyMicePhysiology (medical)Internal medicinemedicineAnimalsCitrate synthaseGlucuronidaseAdenosine TriphosphatasesCardiac muscleActomyosinmedicine.diseaseMyocardial ContractionMitochondria MuscleEndocrinologymedicine.anatomical_structureVentriclebiology.proteinHeart enlargementCardiology and Cardiovascular MedicineOxidation-ReductionBasic Research in Cardiology
researchProduct

Iron Metabolism Contributes to Prognosis in Coronary Artery Disease: Prognostic Value of the Soluble Transferrin Receptor Within the AtheroGene Study

2020

Background Coronary heart disease is a leading cause of mortality worldwide. Iron deficiency, a frequent comorbidity of coronary heart disease, causes an increased expression of transferrin receptor and soluble transferrin receptor levels (sTfR) levels, while iron repletion returns sTfR levels to the normal physiological range. Recently, sTfR levels were proposed as a potential new marker of iron metabolism in cardiovascular diseases. Therefore, we aimed to evaluate the prognostic value of circulating sTfR levels in a large cohort of patients with coronary heart disease. Methods and Results The disease cohort comprised 3423 subjects who had angiographically documented coronary heart diseas…

Malemedicine.medical_specialtyTime FactorsIronMyocardial InfarctionCoronary Artery Disease030204 cardiovascular system & hematologyCoronary AngiographyRisk AssessmentGastroenterologyCoronary artery disease03 medical and health sciences0302 clinical medicinePredictive Value of TestsRisk FactorsGermanyInternal medicineReceptors TransferrinmedicineHumansCoronary Heart Diseasesoluble transferrin receptorAgedOriginal Research030304 developmental biologySoluble transferrin receptorchemistry.chemical_classification0303 health sciencesbiologybusiness.industryMyocardiumMetabolismIron deficiencyMiddle AgedPrognosismedicine.diseaseComorbidityCoronary heart diseasechemistryTransferrinbiology.proteinbiomarkerBiomarker (medicine)FemaleCardiology and Cardiovascular MedicinebusinessBiomarkersJournal of the American Heart Association
researchProduct

Dietary Fatty Acids in Metabolic Syndrome, Diabetes and Cardiovascular Diseases

2011

In the last few decades, the prevalence of overweight and essential obesity has been undergoing a fast and progressive worldwide increase. Obesity has been in turn linked to type II diabetes, with the total number of diabetic patients worryingly increasing, in the last fifteen years, suggesting a pandemic phenomenon. At the same time, an increase in the prevalence of cardiovascular diseases has been also recorded. Increasing evidence suggests that the diet is involved in such escalation. In particular, the progressive globalization of food industry allowed massive supply, at a relatively low price, of a great variety of pre-packed food and bakery products, with very high energy content. Mos…

Malemedicine.medical_specialtycoronary heart disease (CHD)Endocrinology Diabetes and MetabolismTransportCoronary DiseaseType 2 diabetesOverweightEndocrinologyInsulin resistanceRisk FactorsSettore BIO/10 - BiochimicaInternal medicineDiabetes mellitusPrevalencemedicineHumansObesityMetabolic Syndromechemistry.chemical_classificationtype 2 diabeteFree fatty acidbusiness.industryFatty AcidsMetabolismTrans Fatty AcidsFatty acidsignaling fatty acidLipid Metabolismmedicine.diseaseDietary FatsObesityDietMetabolismEndocrinologychemistryFemaleFFA-dependent β-cell apoptosiHydrogenationInsulin Resistancemedicine.symptomMetabolic syndromebusinessDiabetic AngiopathiesPolyunsaturated fatty acidCurrent Diabetes Reviews
researchProduct

Improvement in risk stratification with the combination of the tumour marker antigen carbohydrate 125 and brain natriuretic peptide in patients with …

2010

Aim Elevated brain natriuretic peptide (BNP) and tumour marker antigen carbohydrate 125 (CA125) levels have shown to be associated with higher risk for adverse outcomes in patients with acute heart failure (AHF). Nevertheless, no attempt has been made to explore the utility of combining these two biomarkers. We sought to assess whether CA125 adds prognostic value to BNP in predicting 6-month all-cause mortality in patients with AHF. Methods and results We analysed 1111 consecutive patients admitted for AHF. Antigen carbohydrate 125 (U/mL) and BNP (pg/mL) were measured at a median of 72 ± 12 h after instauration of treatment. Antigen carbohydrate 125 and BNP were dichotomized based on propos…

Malemedicine.medical_specialtyendocrine system diseasesHeart diseasemedicine.drug_classKaplan-Meier EstimateGastroenterologyRisk AssessmentAntigenInternal medicineNatriuretic Peptide BrainNatriuretic peptidemedicineHumansTumor markerAgedAged 80 and overHeart Failurebusiness.industryProportional hazards modelMiddle Agedmedicine.diseaseBrain natriuretic peptidePrognosisEndocrinologyHeart failureCA-125 AntigenAcute DiseaseFemaleCardiology and Cardiovascular MedicineRisk assessmentbusinesshormones hormone substitutes and hormone antagonistsBiomarkersEuropean heart journal
researchProduct

Prognostic Value of New-Generation Troponins in ST-Segment-Elevation Myocardial Infarction in the Modern Era: The RUTI-STEMI Study.

2017

Background In ST ‐segment–elevation myocardial infarction ( STEMI ), troponins are not needed for diagnosis: symptoms and ECG data are sufficient to activate percutaneous coronary intervention. This study explored the prognostic value of new‐generation troponins in a real‐life cohort contemporarily treated for STEMI . Methods and Results We studied 1260 consecutive patients with primary STEMI treated with percutaneous coronary intervention between February 22, 2011, and August 31, 2015. We collected data on clinical characteristics and major adverse cardiovascular and cerebrovascular events ( MACCEs ) at 30 days and 1 year. Peak high‐sensitivity troponin T and sensitive‐contemporary tropon…

Malemedicine.medical_specialtymedicine.medical_treatment030204 cardiovascular system & hematologyCoronary AngiographyVentricular Function Left03 medical and health sciencesElectrocardiography0302 clinical medicinePercutaneous Coronary InterventionPredictive Value of TestsIschemiaInternal medicineCardiovascular DiseaseST segmentMedicineHumansCoronary Heart Disease030212 general & internal medicineMyocardial infarctionST‐segment–elevation myocardial infarctionAgedRetrospective StudiesOriginal ResearchAged 80 and overbiologybusiness.industrytroponinPercutaneous coronary interventionMiddle Agedmedicine.diseasePrognosisTroponinmyocardial infarctionbiology.proteinCardiologyST Elevation Myocardial InfarctionFemaleMortality/SurvivalCardiology and Cardiovascular MedicinebusinessValue (mathematics)BiomarkersJournal of the American Heart Association
researchProduct

Development of comorbidity-adapted exercise protocols for patients with knee osteoarthritis

2014

Mariëtte de Rooij,1 Marike van der Leeden,1,2 Ellis Avezaat,3 Arja Häkkinen,4 Rob Klaver,1 Tjieu Maas,5 Wilfred F Peter,1 Leo D Roorda,1 Willem F Lems,1,6 Joost Dekker1,71Amsterdam Rehabilitation Research Center, Reade, Amsterdam, the Netherlands; 2VU University Medical Center Department of Rehabilitation Medicine, Amsterdam, the Netherlands; 3Sint Lucas Andreas Hospital, Department of Physical Therapy, Amsterdam, the Netherlands; 4Department of Health Sciences, University of Jyväskylä and Jyväskylä Central Hospital, Jyväskylä, Finland; 5HAN University, Institute of Health, GGM, Institute for Sports and Exercise Studies…

Malemedicine.medical_treatmentOsteoarthritislaw.inventionPulmonary Disease Chronic ObstructiveRandomized controlled triallawActivities of Daily LivingOrthopedics and Sports MedicineniveltulehdusHearing DisordersDepression (differential diagnoses)Original Researchkomorbiditeettiexercise therapyRehabilitationDepressionta3141General MedicineMiddle AgedOsteoarthritis KneeLow back paincomorbidityTreatment Outcomearthritiscoexisting diseaseHypertensionFemaleChronic Painmedicine.symptomliikuntahoitomedicine.medical_specialtyHeart DiseasesVision DisordersBiomedical Engineeringknee osteoarthritisrehabilitationRheumatologymental disordersmedicineHumansObesityAgedProtocol (science)business.industryRC952-954.6medicine.diseaseComorbidityDiabetes Mellitus Type 2GeriatricsHeart failureClinical Interventions in AgingQuality of LifePhysical therapykuntoutusGeriatrics and GerontologybusinessLow Back PainClinical Interventions in Aging
researchProduct

Incidence and costs of hip fractures compared to acute myocardial infarction in the Italian population: a 4-year survey

2007

Introduction Few data are available about the incidence and costs of hip fractures in Italy. We aimed to determine the impact of hip fractures vs. acute myocardial infarction (AMI). Methods We studied the national hospitalization database to calculate their incidence and costs in adults aged ≥45 between 1999 and 2002. Results In 2002, there were 86,719 hip fractures with a 10.0% increase over 4 years. We observed a predominance of women (77.1%) and a strong age effect: 92.7% of patients were ≥65 years old and 80% of fractures occurred in women aged ≥75, showing a clear relationship with the incidence of osteoporosis. Hospitalizations due to AMI after 45 years of age in 1999 were only 9% hig…

Malemusculoskeletal diseasesAgingmedicine.medical_specialtyHeart diseaseCostEpidemiologyEndocrinology Diabetes and MetabolismOsteoporosisacute myocardial infarctionPoison controlhip fractures; myocardial infarctionAMIAge Distributionhip fracture myocardial infarction italian populationInjury preventionEpidemiologyHumansMedicinecardiovascular diseasesMyocardial infarctionSex Distributionhealth care economics and organizationsAgedbusiness.industryIncidenceIncidence (epidemiology)Health Care CostsLength of StayMiddle Agedmedicine.diseaseHospitalizationmyocardial infarctionItalyhip fractureHealth Care Surveyship fracturesEmergency medicineOrthopedic surgeryPhysical therapyFemaleitalian populationbusiness
researchProduct

Acute rheumatic fever prophylaxis in high-income countries: clinical observations from an Italian multicentre, retrospective study.

2019

Objective-The aim of the study is to evaluate the compliance rate to secondary prophylaxis and the presence of Rheumatic Heart Disease (RHD) in a cohort of Italian patients with Acute Rheumatic Fever (ARF). Methods-This is a multicentre retrospective study. Patients were divided into two groups according to the presence or absence at last follow-up of RHD. Clinical features, ARF recurrences and the rate of compliance to secondary prophylaxis were evaluated. Results-wo hundred and ninety patients were enrolled (137 females, 153 males). Carditis at onset was present in 244 patients (84.7%). At the end of follow-up, 173 patients showed RHD. Adherence to secondary prophylaxis was low in 26% of …

MaleprophylaxiDeveloped CountriesRheumatic Heart Diseaseacute rheumatic fever; prophylaxis; rheumatic heart diseaseCarditirheumatic heart diseaseAcute rheumatic feveracute rheumatic feverSettore MED/38 - Pediatria Generale E SpecialisticaItalyHumansFemaleprophylaxisProphylaxiRheumatic FeverAcute rheumatic fever Carditis Compliance Prophylaxis Rheumatic heart diseaseComplianceRetrospective StudiesClinical and experimental rheumatology
researchProduct

Cardiac sources of cerebral embolism in people with migraine

2021

Background and purpose Whether the reported association between migraine with aura (MA) and cardioembolic stroke may be explained by a higher rate of atrial fibrillation (AF) or by other potential cardiac sources of cerebral embolism remains to be determined.Methods In the setting of a single centre cohort study of consecutive patients with acute brain ischaemia stratified by migraine status, the association between AF as well as patent foramen ovale (PFO) and migraine was explored.Results In all, 1738 patients (1017 [58.5%] men, mean age 67.9 +/- 14.9 years) qualified for the analysis. Aging was inversely associated with migraine, whilst women had a >3-fold increased disease risk (odds …

Maleyoung adultsmedicine.medical_specialtyHeart DiseasesAuraMigraine DisordersMigraine with AuraMEDLINEForamen Ovale PatentCohort Studies03 medical and health sciences0302 clinical medicinestomatognathic systemCerebral embolismInternal medicinemedicineHumansIn patientmigraine030212 general & internal medicineStrokeAgedAged 80 and overbusiness.industryAtrial fibrillationHeartOdds ratiocardioembolismMiddle Agedmedicine.diseasestrokeMigraine with auraNeurologyEmbolismMigraineIntracranial EmbolismCohortCardiologyPatent foramen ovaleFemaleNeurology (clinical)medicine.symptombusiness030217 neurology & neurosurgeryCohort study
researchProduct

Alteraciones en los pies en ancianos frágiles comunitarios con patología cardíaca. Factores de riesgo

2016

Medicine(all)Cartas al directorlcsh:R5-920Heart Diseasesbusiness.industryFrail ElderlyGeneral Medicine030204 cardiovascular system & hematologyFoot Diseases03 medical and health sciences0302 clinical medicineRisk FactorsHumansMedicineIndependent Living030212 general & internal medicineFamily Practicebusinesslcsh:Medicine (General)Geriatric AssessmentAgedAtención Primaria
researchProduct